(Q44196256)

30 November 2017

title

Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. (English)

1 reference

30 November 2017

1 reference

Virpi Saareks

1

1 reference

30 November 2017

Pauli Ylitalo

series ordinal

2

1 reference

30 November 2017

István Mucha

series ordinal

3

1 reference

30 November 2017

Asko Riutta

series ordinal

4

1 reference

30 November 2017

publication date

1 June 2002

1 reference

Basic and Clinical Pharmacology and Toxicology

30 November 2017

published in

1 reference

30 November 2017

volume

90

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

338-342

1 reference

Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Niacin dosing: relationship to benefits and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Liquid chromatographic studies of vitamin B6 metabolism in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Evaluating niacin in its various forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Increased thromboxane biosynthesis in patients with acute cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Eicosenoid biosynthesis and platelet function with advancing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Platelet activation in unstable coronary disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Transient focal hepatic defects related to sustained-release niacin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

BIO-Fully Automated Sample Treatment high-performance liquid chromatography and radioimmunoassay for leukotriene E4 in human urine from asthmatics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Determination of 9 alpha, 11 beta-prostaglandin F2 in human urine and plasma by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Depressed plasma pyridoxal phosphate concentrations in adult asthmatics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Selective solid-phase extraction of urinary 2,3-dinor-6-ketoprostaglandin F1 alpha for determination with radioimmunoassay

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Effect of pyridoxal 5'-phosphate on human neutrophil aggregation in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

The in vivo effect in humans of pyridoxal-5'-phosphate on platelet function and blood coagulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

Thromboxane and prostacyclin formation in patients with deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

In vivo metabolism of leukotriene C4 in man: urinary excretion of leukotriene E4

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900608.X

7 January 2021

10.1034/J.1600-0773.2002.900608.X

Identifiers

DOI

1 reference

30 November 2017

1 reference